Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
17 Nov - 01 Dec 2011
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report date:
2012

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
adopted Feb 1987
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Version / remarks:
May 2008
Deviations:
not specified
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1200 (Acute Dermal Toxicity)
Version / remarks:
Aug 1998
Deviations:
not specified
Qualifier:
according to guideline
Guideline:
other: Japanese Ministry of Agriculture, Forestry and Fisheries, No 8147
Version / remarks:
Nov 2000
Deviations:
not specified
GLP compliance:
yes (incl. QA statement)
Remarks:
Food and Consumer Product Safety Authority (VWA), Utrecht, The Netherlands
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Silicic acid (H4SiO4), tetraethyl ester, reaction products with bis(acetyloxy)dioctylstannane
EC Number:
300-346-5
EC Name:
Silicic acid (H4SiO4), tetraethyl ester, reaction products with bis(acetyloxy)dioctylstannane
Cas Number:
93925-43-0
Molecular formula:
C4H8O2, C20H44O4SiSn, C24H52O6SiSn, C40H84O8SiSn2, C60H128O12Si2Sn3, C80H172O16Si3Sn4, C100H216O20Si4Sn5
IUPAC Name:
Silicic acid (H4SiO4), tetraethyl ester, reaction products with bis(acetyloxy)dioctylstannane
Specific details on test material used for the study:
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The formulation (w/w) was prepared within 4 hours prior to dosing. Homogeneity was accomplished to a visually acceptable level. Adjustment was made for specific gravity of the vehicle and test substance. In order to obtain homogeneity, the test substance formulation was heated in a water bath with a maximum temperature of 81.1 °C for a maximum of 1 hour and 37 minutes. The test substance formulation was allowed to cool down to a temperature of maximally 40 °C prior to dosing.

Test animals

Species:
rat
Strain:
Wistar
Remarks:
Crl:WI (Han) (outbred, SPF-Quality)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Deutschland, Sulzfeld, Germany
- Females nulliparous and non-pregnant: yes
- Age at study initiation: approximately 10 weeks
- Weight at study initiation: 290 ± 13 g (males); 197 ± 11 g (females);
- Housing: individually housed in labeled Makrolon cages (MIII type, height 18 cm.) containing sterilized sawdust as bedding material and paper as cage-enrichment.
- Diet: SM R/M-Z, pelleted (Ssniff Spezialdiäten GmbH, Soest, Germany), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.0 ± 3.0 (actual range: 19.6 – 21.9)
- Humidity (%): 40 - 70 (actual range: 40 - 56)
- Air changes (per hr): approximately 15
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Type of coverage:
occlusive
Vehicle:
other: hydrogenated corn oil
Details on dermal exposure:
TEST SITE
- Area of exposure: approximately 25 cm² for males; approximately 18 cm² for females
- % coverage: 10
- Type of wrap if used: a surgical gauze patch (Surgy 1D), successively covered with aluminum foil and Coban elastic bandage. A piece of Micropore tape was additionally used for fixation of the bandages in females only.

REMOVAL OF TEST SUBSTANCE
- Washing (if done): residual test material was removed with tap water
- Time after start of exposure: 24 h

TEST MATERIAL
- Concentration: 10 mL/kg bw
Duration of exposure:
24 h
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed twice daily for mortality and morbidity; individual body weights were determined on days 1 (pre-administration), 8, 15 and prior to sacrifice; clinical signs were determined at periodic intervals on the day of dosing (Day 1) and once daily thereafter until Day 15
- Necropsy of survivors performed: yes

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
One female was sacrificed for ethical reasons on Day 8 due to an excessive weight loss.
Clinical signs:
other: Lethargy was noted in 1/5 males on Day 2 and in 4/5 males on Day 1, and recurred in 2/5 males on Day 8. In females lethargy was observed in 3/5 females on Day 1, in 2/5 females on Days 7 or 8. Flat posture was observed in 1/5 males on Day 1. Hunched postu
Gross pathology:
The female that was sacrificed for ethical reasons on Day 8 showed a reduced size of the thymus at macroscopic post mortem examination. No abnormalities were observed at macroscopic post mortem examination in the 9 surviving animals.

Any other information on results incl. tables

Table 1 Clinical signs

Test Days   1 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Hours after dosing   0 2 4                            

Males

Animal 1                                    
Lethargy (3) - 1 1 - - - - - - - - - - - - - -
Hunched posture (1) - 1 1 - - - - - - - - - - - - - -
Flat posture (1) - - - 1 1 1 1 1 - 1 1 1 - - - - -
Piloerection (1) - - 1 1 - - - - - - - - - - - - -
Chromodacryorrhoea (snout) (3) - - - 2 1 - - - - - - - - - - - -
ptosis (3) - 1 1 - - - - - - - - - - - - - -
Animal 2                                    
Lethargy (3) - 1 1 - - - - - - - - - - - - - -
Hunched posture (1) - - - 1 1 1 1 1 - - - - - - - - -
Piloerection (1) - - 1 1 1 - - - - - - - - - - - -
Chromodacryorrhoea (snout) (3) - 1 1 1 - - - - - - - - - - - - -
ptosis (3) - - 1 - - - - - - - - - - - - - -
Animal 3                                    
Lethargy (3) - - - 2 - - - - - - - - - - - - -
Hunched posture (1) - 1 1 1 1 1 1 1 1 1 1 - - - - - -
Piloerection (1) - 1 1 1 1 1 1 1 - 1 - - - - - - -
Chromodacryorrhoea (snout) (3) - 1 1 1 - - - - - - - - - - - - -
ptosis (3) - - 1 1 - - - - - - - - - - - - -
Animal 4                                    
Lethargy (3) - 1 1 - - - - - - 1 - - - - - - -
Hunched posture (3) - - - 1 1 1 1 1 - 1 1 1 - - - - -
Piloerection (1) - - 1 1 1 - - - - 1 1 - - - - - -
Scales (3) - - - - - - - 1 1 1 - - - - - - -
Chromodacryorrhoea (snout) (3) - 1 1 1 - - - - - 1 - - - - - - -
ptosis (3) - 1 1 - - - - - - - - - - - - - -
Animal 5                                    
Lethargy (3) - 1 1 2 - - - - - 1 - - - - - - -
Hunched posture (1) - - - 1 1 1 1 1 1 1 1 1 1 - - - -
Shallow respiration (3) - - - - - - - - - 1 - - - - - - -
Piloerection (3) - 1 1 1 1 - - - - 1 1 - - - - - -
Chromodacryorrhoea (snout) (3) - 1 1 1 - - - - - - - - - - - - -
lean (1) - - - - - - - - - 1 - - - - - - -
ptosis (3) - 1 1 1 - - - - - - - - - - - - -

Females

Animal 6                                    
Lethargy (3) - 1 1 - - - - - - 1 - - - - - - -
Hunched posture (1) - - - 1 1 1 1 1 - 1 1 1 1 - - - -
Piloerection (3) - 1 1 1 1 - - - - 1 1 - - - - - -
Chromodacryorrhoea (snout) (3) - 1 2 2 - - - - - - - - - - - - -
ptosis (3) - 1 1 - - - - - - - - - - - - - -
Animal 7                                    
Restless (3) - - - - - - - - 1 -              
Lethargy (3) - - 1 - - - - - - 1              
Hunched posture (1) - - - 1 1 1 1 1 1 1              
Shallow respiration (3) - - - 2 - - - - - 1              
Piloerection (1) - 1 1 1 1 1 1 1 1 1              
Chromodacryorrhoea (snout) (3) - - - 2 - - - - 1 1              
lean (1) - - - - - - - - - 1              
ptosis (3) - - - - - - - - - 1              
Animal 8                                    
Lethargy (3) - - 1 - - - - - - - - - - - - - -
Hunched posture (1) - - - 1 1 1 1 1 1 1 1 1 - - - - -
Piloerection (1) - - 1 1 1 1 1 1 - - - - - - - - -
Chromodacryorrhoea (snout) (3) - 1 1 2 - - - - - - - - - - - - -
Animal 9                                    
Hunched posture (1) - - - 1 1 1 1 1 1 1 1 1 1 - - - -
Piloerection (1) - - 1 1 1 1 1 1 - - - - - - - - -
Chromodacryorrhoea (snout) (3) - - - 2 - - - - - - - - - - - - -
Animal 10                                    
Lethargy (3) - - - - - - - - - 1 - - - - - - -
Hunched posture (1) - - - 1 - - 1 1 1 1 1 1 1 - - - -
Piloerection (1) - 1 1 1 1 1 1 1 1 1 1 1 1 - - - -
Chromodacryorrhoea (snout) (3) - - - 2 - - - - - 1 - - - - - - -
lean (1) - - - - - - - - - 1 - - - - - - -

Number in brackets = Max score

Table 2 Body weights (gram)

Days 1 8 15
Males
Animal 1 284 274 313
Animal 2 309 306 347
Animal 3 288 271 309
Animal 4 274 265 298
Animal 5 296 268 311
Mean ± SD 290 ± 13 277 ± 17 316 ± 18
Females
Animal 1 199 187 206
Animal 2 189 142 -
Animal 3 188 197 208
Animal 4 194 191 205
Animal 5 214 196 226
Mean ± SD 197 ± 11 183 ± 23 211 ± 10

Applicant's summary and conclusion

Interpretation of results:
other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
Conclusions:
CLP: not classified